Kevin Jon Williams (Kevin J Williams, K J Williams)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Randomized Controlled Trial

Top Venues

Diabetes, obesity & metabolism

Arteriosclerosis, thrombosis, and vascular biology

Lupus science & medicine

Obesity science & practice

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin Jon Williams
Eradicating Atherosclerotic Events by Targeting Early Subclinical Disease: It Is Time to Retire the Therapeutic Paradigm of Too Much, Too Late. Arteriosclerosis, thrombosis, and vascular biology (2023)
Kevin Jon Williams
Arterial Zones That Take a Pause in Early Plaque Development. Arteriosclerosis, thrombosis, and vascular biology (2023)
Kevin Jon Williams, Eran Bashan, Caitlin Kruse, Sajitha Sritharan, Israel Hodish
Time in range in patients with type 2 diabetes who are long-term users of d-Nav®, an artificial intelligence-driven technology for autonomous titration of insulin dosing. Diabetes, obesity & metabolism (2023)
Megan Zhao, Rui Feng, Victoria P Werth, Kevin Jon Williams
State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus. Lupus science & medicine 10 (2) (2023)
Roy Harper, Eran Bashan, Kevin Jon Williams, Sajitha Sritharan, Mark Willis, Deanna J Marriott, Israel Hodish
Challenging the 50-50 rule for the basal-bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control. Diabetes, obesity & metabolism (2022)
Thomas Vazquez, Rui Feng, Kevin Jon Williams, Victoria P Werth
Immunological and clinical heterogeneity in cutaneous lupus erythematosus. The British journal of dermatology 185 (3) (2021)
Cherie Lisa Vaz, Nicholas Carnes, Bobak Pousti, Huaqing Zhao, Kevin Jon Williams
A randomized controlled trial of an innovative, user-friendly, interactive smartphone app-based lifestyle intervention for weight loss. Obesity science & practice 7 (5) (2021)